Dalkhimpharm employees 1,600 men and
women working in various buildings on the
40 acre campus.
Our partner pharmaceutical company, JSC Dalkhimpharm,
located in Khavarovsk Russia, was established in 1939.
It was formerly known as Khabarovsk Chemicals and
|Joint Share Company
In addition to our product, LERA®, the company manufactures medicinal products and drugs, including
painkillers, anti-fever, cardiovascular, cholagogue, analgesic, anti-septic, psychotropic, gastrointestinal,
and antimicrobial drugs.
JSC Dalkhimpharm holds FDA, GMO, GMP, HACCP, and Kosher registrations and certifications, and
complies with all modern and expected standards of excellence.
Our Manufacturing Facility
adaptogen blend per year. That quantity represents about 142 million servings. With little added expense
significant impact on the raw material supply.significant impact on the raw material supply.
We have the capacity to back up production in the event of a disaster that would incapacitate the factory.
The factory is the third largest pharmaceutical factory in Russia. The plant employs more than 1600
employees and its campus covers about 16 hectors of property. The production of adaptogens is a
small part of the manufacturing at the factory. The primary pharmacy items include surgery preparation
kits, ethical drug production and various over-the-counter remedies that appear in apothecaries
Sunrise Global Trading has a contract in place as the exclusive exporter from the factory. The current
contract, initiated in 2000, endures through December 31, 2020 and is renewable. Renewal periods are
10-year periods. Sunrise has staff in Russia that oversees production and helps assure product quality.
The factory is FDA registered and ISO compliant. We are very proud of our relationship with the factory
and we protect our agreement with them. The Russian Government has issued a single license in all of
Russia to our plant and to Sunrise Global Trading for the production of custom co-extraction products.